Bioactive borophosphate glasses

1. A borophosphate glass composition consisting of:

0.1 to 80 mol % B 2 O 3 ,

30 to 80 mol % P 2 O 5 , and

5 to 50 mol % CaO, and

at least two additives selected from:

0.1 to 20 mol % Li 2 O,

0.1 to 20 mol % Na 2 O,

0.1 to 20 mol % K 2 O,

0.1 to 20 mol % Al 2 O 3 ,

0.1 to 10 mol % ZnO,

0.1 to 3.6 mol % MgO,

0.1 to 5 mol % Fe 2 O 3 ,

0.1 to 5 mol % CuO, and

0.1 to 5 mol % TiO 2 , based on a 100 mol % total of the composition.

2. The borophosphate glass composition of claim 1 , wherein any additive selected from the group of Al 2 O 3 , ZnO, MgO, Fe 2 O 3 , and CuO retards the degradation rate of glass formers B 2 O 3 , P 2 O 5 , or both, going from a solid state into a solution state.

3. The borophosphate glass composition of claim 1 , wherein any additive selected from the group of LiO, Na 2 O, and K 2 O increases the degradation rate of the glass composition going from a solid state into a solution state.

4. A bioactive composition, comprising

(a) a borophosphate glass composition consisting of:

0.1 to 80 mol % B 2 O 3 ,

30 to 80 mol % F 2 O 5 , and

5 to 50 mol % CaO, and

at least two additives selected from;

0.1 to 20 mol % Li 2 O,

0.1 to 20 mol % Na 2 O,

0.1 to 20 mol % K 2 O,

0.1 to 20 mol % Al 2 O 3 ,

0.1 to 10 mol % ZnO,

0.1 to 3.6 mol % MgO,

0.1 to 5 mol % Fe 2 O 3 ,

0.1 to 5 mol % CuO, and

0.1 to 5 mol % TiO 2 , based on a 100 mol % total of the borophosphate glass composition; and

(b) a least one live cell.

5. The bioactive composition of claim 4 , wherein the at least one live cell is selected from the group consisting of MC3T3-E1 cells, human umbilical vein endothelial cells, or combinations thereof.

6. The bioactive composition of claim 4 , wherein one of the at least two additives is 0.1 to 6 mol % Al 2 O 3 , and the bioactive composition has an improved biocompatibility compared to the same bioactive composition free of Al 2 O 3 .

7. An article of manufacture comprising the borophosphate glass composition of claim 1 .

8. The article of manufacture of claim 7 , further comprising: at least one form factor selected from: a cell culture article or apparatus; a cell phone cover glass component; a flat or curved panel display component; a structural glass component; a pharmaceutical drug dispensing vial component; a fiber optic component, or a combination thereof.

9. A method of inhibiting the release of at least one of B 2 O 3 and P 2 O 5 present in the borophosphate glass composition of claim 1 into an aqueous solution, wherein the borophosphate glass composition has at least one additive selected from the group consisting of Al 2 O 3 , ZnO, MgO, Fe 2 O 3 , and CuO, the method comprising:

contacting the borophosphate glass composition with an aqueous solution.

10. The method of claim 9 , wherein the aqueous solution is a simulated body fluid, and where the measured inhibition is relative to, or compared with, the same borophosphate glass composition but free of the at least one additive source selected from the group of Al 2 O 3 , ZnO, MgO, Fe 2 O 3 , and CuO.

11. A method of increasing the release of at least one of B 2 O 3 and P 2 O 5 present in the borophosphate glass composition of claim 1 into an aqueous solution, wherein the borophosphate glass composition of claim 1 has at least one additive selected from the group consisting of LiO, Na 2 O, K 2 O, and SiO 2 , the method comprising:

contacting the borophosphate glass composition with a liquid.

12. The method of claim 11 , wherein the liquid is water, an aqueous solution, a simulated body fluid, or mixtures thereof.

13. The method of claim 11 , wherein the contacting is conducted in the presence of at least one entity selected from a cell; a tissue; an organ; a blood vessel, or a combination thereof, and wherein the contacting enhances the bioactivity interaction properties of the composition and the at least one entity for at least one of biocompatibility; angiogenesis; or both biocompatibility and angiogenesis.

14. A method of proliferating cells on a bioactive glass composition in an aqueous solution comprising:

contacting the bioactive glass composition claim 4 in the aqueous solution for a time sufficient to proliferate the at least one live cell.

15. The method of claim 14 , wherein the aqueous solution is a simulated body fluid, and the at least one live cell is a live entity selected from selected from: a cell; a tissue; an organ; a blood vessel, or a combination thereof.

16. The borophosphaLe glass composition of claim 1 , wherein the composition consists of:

0.1 to 80 mol % B 2 O 3 ,

30 to 80 mol % P 2 O 5 , and

5 to 50 mol % CaO, and

at least two additives selected from:

0.1 to 20 mol % Li 2 O,

0.1 to 20 mol % Na 2 O,

0.1 to 20 mol %% K 2 O,

5 to 20 mol % Al 2 O 3 ,

0.1 to 10 mol % ZnO,

0.1 to 5 mol % Fe 2 O 3 ,

0.1 to 5 mol % CuO, and

0.1 to 5 mol % TiO 2 , based on a 100 mol % total of the composition.

17. The borophosphate glass composition of claim 1 , wherein the composition consists of:

0.1 to 80 mol % B 2 O 3 ,

30 to 80 mol % P 2 O 5 , and

5 to 50 mol % CaO, and

at least two additives selected from:

0.1 to 20 mol % Li 2 O,

0.1 to 20 mol % Na 2 O,

5 to 20 mol % Al 2 O 3 ,

0.1 to 5 mol % Fe 2 O 3 ,

0.1 to 5 mol % CuO, and

0.1 to 5 mol % TiO 2 , based on a 100 mol % total of the composition.

18. The borophosphate glass composition of claim 1 , wherein the composition consists of:

0.1 to 80 mol % B 2 O 3 ,

30 to 80 mol % P 2 O 5 ,

5 to 50 mol % CaO,

0.1 to 20 mol % Na 2 O,

5 to 20 mol % Al 2 O 3 , based on a 100 mol % total of the composition.

19. The borophosphate glass composition of claim 1 , wherein the composition consists of:

4 to 80 mol % B 2 O 3 ,

30 to 80 mol % P 2 O 5 ,

5 to 50 mol % CaO,

0.1 to 20 mol % Na 2 O,

5 to 20 mol % Al 2 O 3 , based on a 100 mol % total of the composition.